Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

Nextleaf Solutions says subsidiary completes inaugural bulk-CBD distillate delivery to US-listed, Canadian-based global cannabis company

The company anticipates similar orders on an ongoing basis as global demand and acceptance of CBD-based products continues to increase

Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) (FRA:L0MA) has reported that its subsidiary, Nextleaf Labs Ltd has completed an inaugural bulk-CBD distillate delivery to a US-listed, Canadian-based global cannabis company.

The company added that it anticipates similar orders on an ongoing basis.

While the Canadian cannabis sector continues to mature as the world's largest federally legal cannabis jurisdiction, Nextleaf said the global demand and acceptance of CBD-based products continues to increase.

READ: Nextleaf Solutions wins US patent for therapeutic THC-derived prodrug

The company noted that in December 2020, Israel signed a regulatory amendment permitting the use of CBD in cosmetics and food products, and in February 2021 plant-derived CBD was added as a legal ingredient in cosmetics by a key market regulator for trade in the EU.

According to New Frontier Data, Nextleaf said, US consumer spending on CBD reached $3.8 billion in 2020 and the demand is expected to reach as high as $8 billion by 2025.

"Amidst the global acceptance of CBD as a therapeutic drug, Health Canada has begun the process of reviewing CBD and regulating it differently than THC," said Nextleaf CEO Paul Pedersen in a statement.

"Based on this, we believe the CBD market in Canada is at a fraction of its potential, particularly if CBD products are made available in your local grocers, gas stations, and other traditional points of retail, once the review is complete. We plan on our CBD segment being a major revenue source for Nextleaf thanks to the competitive advantage of our technology and our ability to produce high purity CBD oils at a low cost per molecule.”

Pendersen added: “Completing and delivering the first order with a premium partner is a major milestone for OILS. Working with a partner of this magnitude is further validation of our technology and we are ecstatic to power their CBD-focused brands with OILS' high purity, low-cost CBD ingredients.”

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK